1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Symptom Cluster in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (38.46) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braathen, LR; Dummer, R; Levi-Schaffer, F; Menz, G; Plötz, S; Seitzer, U; Simon, D; Simon, HU; Straumann, A | 1 |
Wang, J; Xu, J; Zhong, JB | 1 |
Huang, XT; Shao, P; Zjang, F | 1 |
Belovezhdov, N; Genova, V; Robeva, R | 1 |
de Boer, M; Koenderman, L; Kuijpers, TW; Mascart-Lemone, F; Roos, D; van Zwieten, R; Verhoeven, AJ | 1 |
Abián, J; Calaf, RE; Closa, D; Folch, E; Gelpí, E; Roselló-Catafau, J | 1 |
Adamides, K; Goudevenos, JA; Katsouras, CS; Kolettis, T; Michalis, LK; Sideris, DA; Tambaki, AP; Tselepis, AD | 1 |
Fukuda, T; Makino, S; Masuzawa, Y; Ojima-Uchiyama, A; Sugiura, T; Waku, K | 1 |
Charbonneau, P; Suisse, A | 1 |
Fettig, O; Staiger, HJ; Theml, H | 1 |
de Souza, V; Matthys, H; Menz, G; Schäufele, A; Schmitz-Schumann, M; Virchow, C; von Felten, A | 1 |
Govaerts, LC; Heymans, HS; Prins, A; Schaap, MC; Schutgens, RB; Sturk, A; ten Cate, JW; Wanders, RJ | 1 |
Chamone, DF; Fujimura, AY; Jamra, M | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Symptom Cluster
Article | Year |
---|---|
[Changes in blood coagulation in glomerulonephritis].
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Glomerulonephritis; Humans; Immune Complex Diseases; Kidney Glomerulus; Microcirculation; Platelet Activating Factor; Platelet Aggregation; Renal Circulation; Syndrome | 1982 |
[Syndrome of multiple organ failure].
Topics: Antibodies, Monoclonal; Eicosanoids; Humans; Interleukin-1; Monitoring, Physiologic; Multiple Organ Failure; Oxygen Consumption; Platelet Activating Factor; Syndrome; Tumor Necrosis Factor-alpha | 1990 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Symptom Cluster
Article | Year |
---|---|
[Effect of Radix notoginseng saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome].
Topics: Aged; Blood Viscosity; Female; Hematologic Diseases; Hemorheology; Humans; Male; Middle Aged; Panax; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Saponins; Syndrome | 2004 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Symptom Cluster
Article | Year |
---|---|
Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
Topics: Asthma; Blood Proteins; Cell Degranulation; Dermatitis, Atopic; Drug Synergism; Eosinophil Granule Proteins; Eosinophilia; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypereosinophilic Syndrome; Interleukin-2; Interleukin-5; Platelet Activating Factor; Receptors, Interleukin-2; Ribonucleases; Syndrome | 2003 |
[Research on relationship of syndrome type and parameters of hemorheology and platelet activation in patients with acute gout arthritis of dampness-heat blockage type and stasis-heat accumulate type].
Topics: Acute Disease; Adult; Aged; Arthritis; Diagnosis, Differential; Female; Gout; Hemorheology; Humans; Male; Medicine, Chinese Traditional; Middle Aged; P-Selectin; Platelet Activating Factor; Platelet Activation; Syndrome | 2006 |
A novel syndrome of severe neutrophil dysfunction: unresponsiveness confined to chemotaxin-induced functions.
Topics: Actins; Antigens, CD; Calcimycin; Calcium; CD18 Antigens; CD4 Antigens; CD8 Antigens; Cell Adhesion; Cell Aggregation; Chemotaxis, Leukocyte; Cytochalasin B; Endothelium, Vascular; Female; Humans; Immunologic Deficiency Syndromes; In Vitro Techniques; Infant, Newborn; Kinetics; Leukocyte Count; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen Consumption; Platelet Activating Factor; Reference Values; Sepsis; Syndrome; T-Lymphocyte Subsets | 1993 |
Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome.
Topics: Adipose Tissue; Adipose Tissue, Brown; Aniline Compounds; Animals; Capillary Permeability; Carbon Radioisotopes; Diglycerides; Esters; Fatty Acids, Monounsaturated; Intestinal Absorption; Lipopolysaccharides; Liver; Macrophages, Alveolar; Male; Plant Oils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Propylene Glycols; Rapeseed Oil; Rats; Rats, Wistar; Syndrome; Tissue Distribution; Tritium | 2001 |
Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Coronary Disease; Electrocardiography; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Sensitivity and Specificity; Syndrome | 2002 |
Production of platelet-activating factor by human normodense and hypodense eosinophils.
Topics: Eosinophilia; Eosinophils; Humans; In Vitro Techniques; Kinetics; Neutrophils; Platelet Activating Factor; Reference Values; Syndrome; Time Factors | 1991 |
[Thrombotic thrombocytopenic purpura (Moschcowitz syndrome) in a patient with EPH gestosis. The pathophysiologic principle of HELLP syndrome? On the question of the identity of the HELLP syndrome with thrombotic thrombocytopenic purpura].
Topics: Adult; Blood Coagulation Factors; Blood Platelets; Endothelium, Vascular; Epoprostenol; Female; Humans; Plasma Exchange; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Pre-Eclampsia; Pregnancy; Purpura, Thrombotic Thrombocytopenic; Risk Factors; Syndrome | 1989 |
Evidence of PAF release and platelet activation in analgesics-asthma-syndrome.
Topics: Aspirin; Asthma; Blood Platelets; Collagen; Drug Synergism; Female; Humans; Male; Platelet Activating Factor; Syndrome | 1987 |
Age-related deficiency of the synthesis of platelet activating factor by leukocytes from Zellweger patients.
Topics: Abnormalities, Multiple; Aging; Brain; Erythrocytes; Humans; Kidney; Leukocytes; Liver; Phosphatidylethanolamines; Platelet Activating Factor; Syndrome | 1987 |
Increased levels of eosinophil-derived PAF-acether activity in a patient with idiopathic hypereosinophilic syndrome.
Topics: Adult; Eosinophilia; Female; Humans; Platelet Activating Factor; Syndrome; Thrombosis | 1986 |